These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7197584)

  • 1. Comparison of the iv and ip routes of administration of cisplatin in dogs.
    Pretorius RG; Petrilli ES; Kean CK; Ford LC; Hoeschele JD; Lagasse LD
    Cancer Treat Rep; 1981; 65(11-12):1055-62. PubMed ID: 7197584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs.
    Hardie EM; Page RL; Williams PL; Fischer WD
    Am J Vet Res; 1991 Nov; 52(11):1821-5. PubMed ID: 1686160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
    Casper ES; Kelsen DP; Alcock NW; Lewis JL
    Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL; LeRoy AF; Guarino AM
    Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.
    Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG
    Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice.
    Iwamoto Y; Kawano T; Uozumi J; Aoki K; Baba T
    Cancer Treat Rep; 1984 Nov; 68(11):1367-73. PubMed ID: 6541970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.
    Ogilvie GK; Fettman MJ; Jameson VJ; Walters LM; Lafferty MH; Cooper MF; Powers BE; Ciekot PA; Atwater SW; Withrow SJ
    Am J Vet Res; 1992 Sep; 53(9):1666-9. PubMed ID: 1416374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The comparison of absorptive routes of intraperitoneal infusion with cisplatin in dogs].
    Namatame K; Kou Y; Sasaki E; Nakayoshi A
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1716-9. PubMed ID: 1530339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of cis-dichlorodiammineplatinum (II): distribution, clearance, and toxicity.
    Lagasse LD; Pretorius RG; Petrilli ES; Ford LC; Hoeschele J; Kean C
    Am J Obstet Gynecol; 1981 Apr; 139(7):791-8. PubMed ID: 7193975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms.
    Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty M; Powers BE; Henkel SE; Withrow SJ
    J Am Vet Med Assoc; 1993 Jun; 202(11):1845-8. PubMed ID: 8320153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice.
    Nagase M; Nomura T; Nakajima T
    Cancer Treat Rep; 1987 Sep; 71(9):825-9. PubMed ID: 3621215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a short-term saline diuresis protocol for the administration of cisplatin.
    Ogilvie GK; Krawiec DR; Gelberg HB; Twardock AR; Reschke RW; Richardson BC
    Am J Vet Res; 1988 Jul; 49(7):1076-8. PubMed ID: 3421531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T; Oku M; Kiyozuka Y; Ninomiya Y; Hino K; Okamura Y; Maruyama M; Ichijo M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy using cisplatin by subcutaneous administration.
    Dernell WS; Withrow SJ; Straw RC; Lafferty MH
    In Vivo; 1997; 11(4):345-50. PubMed ID: 9292302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine retroviral vector producer cells survival and toxicity in the peritoneal cavity of dogs.
    Link CJ; Moorman DW; Ackerman M; Levy JP; Seregina T
    In Vivo; 2000; 14(5):635-41. PubMed ID: 11212841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
    Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
    J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rhIL-11 on normal dogs and after sublethal radiation.
    Nash RA; Seidel K; Storb R; Slichter S; Schuening FG; Appelbaum FR; Becker AB; Bolles L; Deeg HJ; Graham T
    Exp Hematol; 1995 May; 23(5):389-96. PubMed ID: 7720811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.